GlassScriptPhysician profile
James Ciancarelli
NPI 1104279884
$7,777.28
in general payments reported to CMS, 2019-2025
19 companies · $3,822 in 2025
The $3,822 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $267 · 2021: $99.63 · 2022: $705 · 2023: $174 · 2024: $2,710 · 2025: $3,822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $3,500 · Travel and Lodging: $2,344 · Food and Beverage: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $3,500.00 |
| Travel and Lodging | $2,343.97 |
| Food and Beverage | $862.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $3,547.71 | 2024-2025 | Lifevest |
| Inari Medical, INC. | $2,599.28 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $452.27 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $392.49 | 2021-2025 | Jardiance |
| Amgen INC. | $186.10 | 2020-2023 | Repatha |
| Becton, Dickinson and Company | $169.32 | 2025 | Swan-Ganz Ccombo |
| Chiesi USA, INC. | $76.78 | 2021-2023 | Cleviprex, Kengreal |
| Angiodynamics, INC. | $58.39 | 2024-2025 | Alphavac |
| E.R. Squibb & Sons, L.L.C. | $46.74 | 2020-2022 | |
| Astellas Pharma US INC | $37.11 | 2021-2022 | |
| Lantheus Medical Imaging, INC. | $31.85 | 2022 | |
| Pfizer INC. | $29.25 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $28.89 | 2025 | |
| Edwards Lifesciences Corporation | $28.48 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.03 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $18.20 | 2025 | Clottriever Bold Catheter |
| Abiomed | $16.96 | 2024 | Impella |
| Medtronic, INC. | $15.49 | 2024 | Invos |
| Astrazeneca Pharmaceuticals LP | $14.94 | 2023 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ciancarelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.